Relationships of MMP-9, E-Cadherin, and VEGF Expression With Clinicopathological Features and Response to Chemosensitivity in Gastric Cancer

Tumor Biology - United States
doi 10.1177/1010428317698368
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Expression of STAT3, MMP-1 and TIMP-1 in Gastric Cancer and Correlation With Pathological Features

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2012English

Expression of VEGF and MMP-9 and MRI�imaging Changes in Cerebral Glioma

Oncology Letters
Cancer ResearchOncology
2011English

Expression Analysis of VEGF-A and VEGF-B: Relationship With Clinicopathological Parameters in Bladder Cancer

Oncology Reports
MedicineCancer ResearchOncology
2009English

Differential Expression of E-Cadherin and P-Cadherin in pT3 Prostate Cancer: Correlation With Clinical and Pathological Features

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2018English

The Relationships Between the Immunoexpression of KAI1, MMP-2, MMP-9 and Steroid Receptors Expression in Endometrial Cancer

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2014English

MMP-2 but Not MMP-9 Associated With COX-2 and Survival in Gastric Cancer

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Figure 1: VEGF Family Members and MMP-9 mRNA Expression in Esophageal Cancer (EC) According to Bioinformatics Analysis.

English

Expression of BNIP3 in Invasive Breast Cancer: Correlations With the Hypoxic Response and Clinicopathological Features

BMC Cancer
Cancer ResearchOncologyGenetics
2009English

Alterations of MUC1 and MUC3 Expression in Gastric Carcinoma: Relevance to Patient Clinicopathological Features

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy